Last Price
273.61
Today's Change
-2.31 (0.83%)
Day's Change
273.61 - 276.23
Trading Volume
1,574
Market Cap
8 Billion
Shares Outstanding
30 Million
Avg Volume
288,712
Avg Price (50 Days)
255.43
Avg Price (200 Days)
230.05
PE Ratio
31.72
EPS
8.53
Earnings Announcement
12-Feb-2024
Previous Close
275.92
Open
273.61
Day's Range
270.5 - 275.8
Year Range
167.0 - 287.0
Trading Volume
184,478
1 Day Change
-1.94%
5 Day Change
-1.96%
1 Month Change
8.11%
3 Month Change
1.38%
6 Month Change
30.60%
Ytd Change
29.91%
1 Year Change
30.56%
3 Year Change
110.80%
5 Year Change
352.78%
10 Year Change
873.66%
Max Change
873.66%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.